Ewa Gogola

5.3k total citations
11 papers, 812 citations indexed

About

Ewa Gogola is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Ewa Gogola has authored 11 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 2 papers in Biotechnology. Recurrent topics in Ewa Gogola's work include CRISPR and Genetic Engineering (6 papers), DNA Repair Mechanisms (6 papers) and PARP inhibition in cancer therapy (6 papers). Ewa Gogola is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), DNA Repair Mechanisms (6 papers) and PARP inhibition in cancer therapy (6 papers). Ewa Gogola collaborates with scholars based in Netherlands, Switzerland and United Kingdom. Ewa Gogola's co-authors include Jos Jonkers, Sven Rottenberg, Marieke van de Ven, Alexandra A. Duarte, Panagiotis A. Konstantinopoulos, Hatice Yücel, Raphaël Ceccaldi, Alan D. D’Andrea, Beatrice Rondinelli and Sohvi Blatter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The EMBO Journal.

In The Last Decade

Ewa Gogola

11 papers receiving 811 citations

Peers

Countries citing papers authored by Ewa Gogola

Since Specialization

Citations

This map shows the geographic impact of Ewa Gogola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Gogola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Gogola more than expected).

Fields of papers citing papers by Ewa Gogola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Gogola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Gogola. The network helps show where Ewa Gogola may publish in the future.

Co-authorship network of co-authors of Ewa Gogola

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Gogola. A scholar is included among the top collaborators of Ewa Gogola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Gogola. Ewa Gogola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair 2024 ·The EMBO Journal ·(unknown), Kamila Burdová, Diego Dibitetto, Cor Lieftink, Elke Malzer, Hendrik J. Kuiken, Ewa Gogola, Arnab Ray Chaudhuri, Roderick L. Beijersbergen, Hana Hanzlíková, Jos Jonkers, Sven Rottenberg	14
2	A histone deacetylase 3 and mitochondrial complex I axis regulates toxic formaldehyde production 2023 ·Science Advances ·(unknown), Ewa Gogola, James A. West, (unknown), Rachel Seear, (unknown), Guillermo Burgos-Barragan, Meng Wang, Patrycja A. Krawczyk, Daphne H. E. W. Huberts, Fanni Gergely, Nicholas J. Matheson, Arthur Kaser, James A. Nathan, Ketan J. Patel	8
3	The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells 2018 ·Cell Reports ·Marco Barazas, Stefano Annunziato, Stephen J. Pettitt, Inge de Krijger, (unknown), Stefan J. Roobol, Catrin Lutz, Jessica Frankum, Fei Song, Rachel Brough, Bastiaan Evers, Ewa Gogola, Jinhyuk Bhin, Marieke van de Ven, Dik C. van Gent, Jacqueline J.L. Jacobs, J. Ross Chapman, Christopher J. Lord, Jos Jonkers, Sven Rottenberg	102
4	Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated Carcinomas 2018 ·Cell Reports ·Khyati Meghani, (unknown), Alexandre Detappe, Pascal Drané, Ewa Gogola, Sven Rottenberg, Jos Jonkers, Ursula A. Matulonis, Elizabeth M. Swisher, Panagiotis A. Konstantinopoulos, Dipanjan Chowdhury	62
5	Resistance to PARP Inhibitors: Lessons from Preclinical Models of BRCA-Associated Cancer 2018 ·Ewa Gogola, Sven Rottenberg, Jos Jonkers	43
6	Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells 2017 ·Nature Communications ·Pepijn M. Schoonen, Francien Talens, (unknown), Ewa Gogola, Anne Margriet Heijink, Peter Bouwman, Floris Foijer, Madalena Tarsounas, Sohvi Blatter, Jos Jonkers, Sven Rottenberg, Marcel A.T.M. van Vugt	87
7	BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance 2017 ·Nature Methods ·Alexandra A. Duarte, Ewa Gogola, Norman Sachs, Marco Barazas, Stefano Annunziato, Julian R. de Ruiter, Arno Velds, Sohvi Blatter, Julia M. Houthuijzen, Marieke van de Ven, Hans Clevers, Piet Borst, Jos Jonkers, Sven Rottenberg	98
8	EZH2 promotes degradation of stalled replication forks by recruiting MUS81 through histone H3 trimethylation 2017 ·Nature Cell Biology ·Beatrice Rondinelli, Ewa Gogola, Hatice Yücel, Alexandra A. Duarte, Marieke van de Ven, (unknown), Panagiotis A. Konstantinopoulos, Jos Jonkers, Raphaël Ceccaldi, Sven Rottenberg, Alan D. D’Andrea	256
9	Studying cancer drug resistance using BRCA-deficient mouse mammary tumor organoids 2017 ·Protocol Exchange ·Alexandra A. Duarte, Ewa Gogola, Norman Sachs, Marco Barazas, Stefano Annunziato, Julian R. de Ruiter, Arno Velds, Sohvi Blatter, Julia M. Houthuijzen, Marieke van de Ven, Hans Clevers, Piet Borst, Jos Jonkers, Sven Rottenberg	1
10	TRIM28 Is an Epigenetic Barrier to Induced Pluripotent Stem Cell Reprogramming 2016 ·Stem Cells ·Denise C. Miles, Nienke A. de Vries, (unknown), Cor Lieftink, Waseem Akhtar, Ewa Gogola, Inka Pawlitzky, Danielle Hulsman, Ellen Tanger, Martijn Koppens, Roderick L. Beijersbergen, Maarten van Lohuizen	46
11	Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer 2015 ·Proceedings of the National Academy of Sciences ·Linda Henneman, Martine H. van Miltenburg, Ewa M. Michalak, Tanya M. Braumuller, Janneke E. Jaspers, Anne Paulien Drenth, Renske de Korte‐Grimmerink, Ewa Gogola, Károly Szuhai, Andreas Schlicker, Rahmen Bin Ali, Colin E.J. Pritchard, Ivo J. Huijbers, Anton Berns, Sven Rottenberg, Jos Jonkers	95

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact